<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="660750" id="root" date="1997-06-13" xml:lang="en">
<title>DENMARK: Neurosearch rises 145 pct in first year.</title>
<headline>Neurosearch rises 145 pct in first year.</headline>
<dateline>COPENHAGEN 1997-06-13</dateline>
<text>
<p>Danish drug company Neurosearch marked its first anniversary of trade on the Copenhagen Stock Exchange on Friday with its share a healthy 145 percent up on the initial offer price.</p>
<p>Launched at 170 crowns per share in an offering which was oversubscribed 17 times, it ended its first day of trade on June 14, 1996 at 227 crowns.</p>
<p>It opened on Friday at 416.00 crowns.</p>
<p>The company was set up by six researchers who left vitamin manufacturer Ferrosan after its 1986 takeover by local giant Novo Nordisk.</p>
<p>It specialises in the discovery and development of new drugs for the treatment of disorders to the central nervous system.</p>
<p>Its brasofensine drug for the treatment of Parkinson's disease is now undergoing phase II clinical trials in Denmark in collaboration with U.S. drug giant Bristol-Myers Squibb.</p>
<p>Neurosearch expects to apply to start clinical trials of a new anti-depressant around the end of the year and to select for further development at least one compound for the treatment of dementia or for protection against brain damage following transient cardiac arrest or a stroke.</p>
<p>The company made net profits of 3.4 million crowns on turnover of 49.0 million in 1996, down from profit of 4.5 million and turnover of 53.7 million the year before.</p>
<p>It paid no dividend.</p>
<p>Together with a subsequent exercise of stock options last year's offering raised 237.9 million crowns.</p>
<p>--Steve Weizman, Copenhagen newsroom +45 33969650</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="DEN">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-13"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-13"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C14">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-13"/>
  </code>
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-13"/>
  </code>
  <code code="C152">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-13"/>
  </code>
  <code code="C17">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-13"/>
  </code>
  <code code="C171">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-13"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-06-13"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-06-13"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-06-13"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="COPENHAGEN"/>
<dc element="dc.creator.location.country.name" value="DENMARK"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
